Search the Newsreel

Davide Campari-Milano N.V.: prezzo obiettivo e consensus degli analisti| CPR | NL0015435975| MarketScreener Italia

Ameriprise Financial (AMP) Earnings Date and Reports 2026 $AMP

Streamplay Studio Grants Over 11 Million Shares in Equity-Based Compensation

Streamplay Studio Seeks ASX Quotation for Employee and Consultant Share Issuance

Do Wall Street Analysts Like Amphenol Stock?

3d illustration inflation and deflation graph by Deepadesigns via Shutterstock Amphenol Corporation (APH) is a global manufacturer of electrical, electronic, and fiber-optic connectivity products. Headquartered in Wallingford, Connecticut, the company's product portfolio spans connectors, cables, antennas, sensors, and circuit boards for a wide range …

Amplia Therapeutics (ASX:ATX) Expands Narmafotinib Program Through Lung Cancer Trial

Streamplay Studio Issues 11,043,671 Shares to Employees and Consultants in Lieu of Bonuses and Fees

AmpliTech Group, Inc. Q2 2026: Revenue $8.07M, EPS $(0.12) — 10-Q Summary

AmpliTech Group, Inc. reported its Q2 2026 financial results, showing a decrease in revenue to $8.07M from $11.03M in the prior year, alongside a wider net loss of $3.09M and a diluted loss per share of $0.12. The company noted improved gross profit due …

Why Sampo Oyj (HLSE:SAMPO) Is Getting Attention Today

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Q2 earnings and buyback completion put Sampo Oyj in focus Sampo Oyj (HLSE:SAMPO) has …

AmpliTech outlines 2026 priorities while declining to reaffirm $50M full-year revenue guidance amid deployment timing shifts

Earnings Call Insights: AmpliTech Group, Inc. (AMPG) Q2 2026 MANAGEMENT VIEW * CEO Fawad Maqbool described Q2 as “an important period in AmpliTech's continued transformation and growth,” adding that results reflected “a deliberate increase in investment as we position AmpliTech to pursue and support …

Amprius Technologies | 8-K: Current report

This document is an 8-K current report filed by Amprius Technologies. The content provided is simply "Document", indicating that the full details of the report are contained within the filing itself, which is not extracted here.

LiveRamp (RAMP) director Vivian Chow receives 1,058-share equity grant

LiveRamp Holdings, Inc. director Vivian Chow received an equity grant of 1,058 shares of common stock on August 12, 2026, as part of her compensation for service. These shares were issued at $0.00 per share, increasing her directly held position to 31,263 shares. The …

CAMP4 Therapeutics Corporation (CAMP) Reports Q2 Loss, Tops Revenue Estimates

CAMP4 Therapeutics Corporation (CAMP) reported a Q2 loss of $0.22 per share, outperforming the Zacks Consensus Estimate of a $0.24 loss. The company's revenues for the quarter ended June 2026 reached $1.78 million, surpassing estimates by 31.78%. Despite beating earnings and revenue expectations, CAMP …

LiveRamp Director Vivian Chow Awarded 1,058 Shares as Part of Board Compensation

Vivian Chow, a director at LiveRamp Holdings, Inc. (NYSE: RAMP), received 1,058 shares of common stock on August 12, 2026, as compensation for her board service. This transaction increases her direct beneficial ownership to 31,263 shares. The shares were granted at no cost, indicating …

Earnings call transcript: AmpliTech Group Q2 2026 revenue miss sparks sharp selloff

AmpliTech Group reported Q2 2026 revenue of $8.07 million, significantly missing Wall Street's forecast of $13 million, leading to a sharp selloff in its stock. The company attributed the revenue miss to customer deployment timing shifts and subsequently withdrew its full-year guidance. Despite a …

AmpliTech Group (NASDAQ:AMPG) Posts Quarterly Earnings Results, Misses Estimates By $0.10 EPS

AmpliTech Group (NASDAQ:AMPG) reported a quarterly loss of $0.12 per share, missing analyst estimates by $0.10, although revenue of $8.07 million slightly exceeded expectations. Following these results, the company's stock fell 6.6% to $5.99. Insider selling of shares has also been noted, while analysts …

AmpliTech Group, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:AMPG) 2026-08-13

CAMP4 Q2 Loss Widens to $33.5M; EPS Misses Estimates

CAMP4 Therapeutics reported a Q2 net loss of $33.5 million, significantly wider than the previous year, primarily due to a $20.9 million non-cash derivative loss, causing EPS of $(0.58) to miss estimates. Despite missing revenue consensus, the company's revenue rose 18.8% year-over-year. Post-quarter, CAMP4 …

U.S. Retail Stocks Worth Watching As Cooling Inflation Eases Pressure On Big Ticket Spending

This article examines three U.S. consumer discretionary and retail stocks—MarineMax (HZO), Winnebago Industries (WGO), and Camping World Holdings (CWH)—that could benefit from cooling inflation and a less aggressive Federal Reserve. These companies, operating in sectors dependent on big-ticket spending, are navigating shifting economic conditions, …

LiveRamp Holdings (RAMP) director granted 1,058-share equity award

LiveRamp Holdings, Inc. director Debora B. Tomlin was granted an equity compensation award of 1,058 shares of common stock on August 12, 2026, as part of her compensation for board service. These shares were issued at $0.00 per share, increasing her directly held stake …

LiveRamp (RAMP) director Timothy Cadogan awarded 1,058 common shares as compensation

LiveRamp Holdings, Inc. director Timothy R. Cadogan was granted 1,058 shares of common stock as part of his compensation for board service, increasing his direct holdings to 62,157 shares. The shares were awarded at $0.00 per share, as detailed in a recent Form 4 …

Form 8K Amprius Technologies Inc For: 13 August By Investing.com

This article reports on Amprius Technologies Inc.'s Form 8K filing for August 13. It notes the stock symbol AMPX with a gain of 5.95%. The content is brief and primarily serves as an announcement for the SEC filing.

AmpliTech Group Reports Q2 2026 Revenue of $8.07 Million, up 50.9% Sequentially, and Gross Profit Growth of 161.2% Year-over-Year

AmpliTech Group announced strong financial results for Q2 2026, with revenue reaching $8.07 million, a 50.9% sequential increase, and gross profit soaring by 161.2% year-over-year to $2.25 million. The company is actively scaling commercialization across its 5G/telecommunications, SATCOM, defense, and semiconductor markets, supported by …

ChampionsGate Acquisition (CHPG) earns $1.15M on trust income but flags going concern risk

ChampionsGate Acquisition Corp (CHPG) reported a net income of $1.15 million for the first half of 2026, primarily from $1.36 million in interest and dividend income from its U.S. Treasury-based trust account. However, the SPAC disclosed a working capital deficit and expressed substantial doubt …

AmpliTech Group (NASDAQ: AMPG) grows Q2 revenue to $8.07M, widens loss

AmpliTech Group (AMPG) lifts margins, raises cash and okays $10M buyback

T Stamp Inc. (IDAI) posts $4.9M loss and takes on $5M Streeterville note

T Stamp Inc. (IDAI) reported a net loss of $4.93 million and operating cash outflows of $4.09 million for the six months ended June 30, 2026, alongside an accumulated deficit of $74.71 million. The company secured a $5 million promissory note from Streeterville Capital, …

CAMP4 Therapeutics (CAMP) widens Q2 2026 loss, boosts cash runway to 2028

CAMP4 Therapeutics reported a wider net loss of $33.5 million in Q2 2026, primarily due to a non-cash loss from a derivative liability. Despite this, the company's research and collaboration revenue increased, and it successfully extended its cash runway through the end of 2028 …

CAMP4 Therapeutics (Nasdaq: CAMP) widens loss as derivative liability surges

CAMP4 Therapeutics reported a widened net loss of $51.86 million for the six months ended June 30, 2026, primarily due to a $27.12 million non-cash charge from the remeasurement of a derivative tranche liability. Despite the loss, the company extended its cash runway through …

CAMP4 Reports Second Quarter 2026 Financial Results and Corporate Highlights

CAMP4 Therapeutics announced its Q2 2026 financial results and corporate highlights, including securing regulatory clearance in Australia and Argentina for its Phase 1/2 clinical trial of CMP-002 for SYNGAP-1 related disorder, with trial initiation expected in Q4 2026. The company also raised an additional …

Will Rising Productivity, Tech Investment and Dividend Stability Reshape Ameriprise Financial's (AMP) Core Narrative?

Ameriprise Financial's Q2 2026 results show strong growth in sales, revenue, and net income, with increased basic and diluted EPS. Management attributes this success to higher adviser productivity, strong client engagement, and technology investments. The company affirmed its quarterly dividend of US$1.70 per share, …

Amplify Energy: Why The Macro Data Demands A Capital Rotation (NYSE:AMPY)

3 Reasons Investors Love Amphenol (APH)

3 Reasons Investors Love Amphenol (APH) Amphenol trades at $168 per share and has stayed right on track with the overall market, gaining 16.6% over the last six months. At the same time, the S&P 500 has returned 11.7%. Is now a good time …

3 Reasons We’re Fans of Ameriprise Financial (AMP)

3 Reasons We're Fans of Ameriprise Financial (AMP) Ameriprise Financial has followed the market's trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 14.8% to $557.69 per share while the index has gained 11.7%. …

Trust Stamp reports 22% revenue increase in first half of 2026

Trust Stamp posts 22% revenue growth in H1, expands African telecom work

Trust Stamp posts 22% revenue growth in H1, expands African telecom work Proactive uses images sourced from Shutterstock Trust Stamp Inc (NASDAQ:IDAI, ISE:AIID) said its revenue for the six-month period ended June 30 increased 22% year-over-year, driven largely by higher revenue from its S&P …